Skip to main content
. 2012 Jan 18;119(6):699–709. doi: 10.1111/j.1471-0528.2011.03228.x

Table 2.

Base-case assumptions on costs, and level and duration of lost utility for different events and health states (costs are given in 2010 prices)

Type of test Category Costs (€) Utilities lost

Level Duration

Invitation 4.74 0
Primary cytology* Laboratory costs 21.77** 0.006 2 weeks
Organisation 11.23
GP costs 11.76
Time/travel 6.01
Programme costs 2.08
Repeat cytology GP costs 22.21 0.006 Time since last test***
Laboratory costs 26.54**
Time/travel 6.01
Primary HPV test**** Laboratory costs 33.87 0.006 2 weeks
Organisation 11.23
GP costs 11.76
Time/travel 6.01
Programme costs 2.08
Repeat HPV test GP costs 22.21 0.006 Time since last test***
Laboratory costs 33.87
Time/travel 6.01
Diagnosis and treatment pre-invasive stages False positive referral 284 0.005 0.5 year
CIN 1 886 0.03 0.5 year
CIN 2 1312 0.07 1 year
CIN 3 1536 0.07 1 year
Diagnosis and treatment invasive cancer FIGO 1A 5031 0.062 5 years
FIGO 1B 11 930 0.062 5 years
FIGO 2+ (detected by screening) 11 758 0.28 5 years
FIGO 2+ (clinically detected) 10 982 0.28 5 years
Terminal care 26 717 0.712 1 month
*

We assumed additional co-collection costs of €1 (for conventional cytology) or €0 (for LBC) to collect the material for a triage HPV test during a primary cytology test.

**

For LBC, the costs are €33.72 for a primary test and €38.49 for a repeat test.

***

The time since the last test can be 0 weeks (in the case of co-collection during the primary test), 2 weeks (if a woman is invited for a repeat test immediately after a positive primary test), 6 or 12 months.

****

We assumed additional co-collection costs of €1 (conventional cytology) or €3 (for LBC) to collect the material for a triage cytology test during a primary HPV test.